VEGFA and melanoma: Therapeutic effects of antiangiogenic agents in melanoma brain metastases have been examined in a few preclinical studies [22–24], and these studies have provided varying results, possibly reflecting a complex role of angiogenesis and VEGF-A in the formation and growth of metastases in the brain [1].